Bone marrow fibrosis and disease activity in multiple myeloma monitored by the aminoterminal propeptide of procollagen III in serum

British Journal of Haematology

Volumn 99, Issue 3, 1997, Pages 641-648

  Abildgaard, N ^a   Bendix Hansen, K ^a   Kristensen, J E ^a   Vejlgaard, T ^a   Risteli, L ^b   Nielsen, J L ^a   Heickendorff, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Bone marrow fibrosis; Collagen metabolism; Disease progression; Multiple myeloma; Treatment response

Indexed keywords

COLLAGEN; PROCOLLAGEN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR CLONING; MULTIPLE MYELOMA; MYELOFIBROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0030701943     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4503260.x     Document Type: Article

References (19)

1. Abildgaard, N., Bentzen, S.M., Nielsen, J.L. & Heickendorff, L. (1997) Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal propeptide of type I collagen (ICTP). British Journal of Haematology, 96, 103-110.
2. Abildgaard, N., Brixen, K., Kristensen, J.E., Vejlgaard, T., Charles, P. & Nielsen, J.L. (1996) Assessment of bone involvement in multiple myeloma using bone densitometry. European Journal of Haematology, 57, 370-376.
3. Abildgaard, N., Nielsen, J.L. & Heickendorff, L. (1994) Connective tissue components in serum in multiple myeloma: analyses of propeptides of type I and type III procollagens, type I collagen telopeptide, and hyaluronan. American Journal of Hematology, 46, 173-178.
4. Apaja-Sarkkinen, M., Autio-Harmainen, H., Alavaikko, M., Risteli, J. & Risteli, L. (1986) Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis. British Journal of Haematology, 63, 571-580.
5. Bartl, R., Frisch, B., Fateh-Moghadam, A., Kettner, G., Jaeger, K. & Sommerfeld, W. (1987) Histologic classification and staging of multiple myeloma: a retrospective and prospective study of 674 cases. American Journal of Clinical Pathology, 87, 342-355.
6. Bentley, S.A., Alabaster, O. & Foidart, J.M. (1981) Collagen heterogeneity in normal human bone marrow. British Journal of Haematology, 48, 287-291.
7. Durie, B.G.M. & Salmon, D.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer, 36, 842-54.
8. 2-microglobulin in myeloma: a Southwest Oncology Group Study. Blood, 75, 823-830.
9. Grimaud, J.A., Druguet, M., Peyrol, S., Chevallier, O., Herbage, D. & El Badrawy, N. (1980) Collagen immunotyping of basement membrane proteins in normal and fibrotic human liver: light and electron microscopic study. Journal of Histochemistry and Cytochemistry, 28, 1145-1156.
10. Krzyzaniak, R.L., Buss, D.H., Cooper, M.P. & Well, H.B. (1988) Marrow fibrosis and multiple myeloma. American Journal of Clinical Pathology, 89, 63-68.
11. Lisse, I., Hasselbalch, H. & Junker, P. (1991) Bone marrow stroma in idiopathic myelofibrosis and other haematological diseases. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 99, 171-178.
12. Riccardi, A., Ucci, G., Coci, G. & Ascari, E. (1988) Bone marrow fibrosis in multiple myeloma. American Journal of Clinical Pathology, 90, 753-754.
13. Risteli, J., Elomaa, I., Niemi, S., Novamo, A. & Risteli, L. (1993) Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clinical Chemistry, 39, 635-640.
14. Risteli, J., Niemi, S., Trivedi, P., Maentausta, O., Mowat, A.P. & Risteli, L. (1988) Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clinical Chemistry, 34, 715-718.
15. Smedsrod, B. (1988) Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor mediated endocytosis in liver endothelial cells. Collagen and Related Research, 8, 375.
16. Sonneveld, P., Schoester, M. & de Leeuw, K. (1991) In vitro Ig-synthesis and proliferative activity in multiple myeloma are stimulated by different growth factors. British Journal of Haematology, 79, 589-594.
17. Tanabe, O., Kawano, M., Tanaka, H., Iwato, K., Asaoku, H., Ishikawa, H., Nobuyoshi, M., Hirano, T., Kishimoto, T. & Kuramoto, A. (1989) BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cells. American Journal of Hematology, 31, 258-262.
18. Taube, T., Franssila, K., Risteli, L., Risteli, J. & Elomaa, I. (1992) Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP). British Journal of Haematology, 82, 32-37.
19. Vacca, A., Ribatti, D., Roncalli, L., Ranieri, G., Serio, G., Silvestris, F. & Dammacco, F. (1994) Bone marrow angiogenesis and progression in multiple myeloma. British Journal of Haematology, 87, 503-508.